Meeting
2018 Gastrointestinal Cancers Symposium
Effect of stereotactic radiation (SBRT) on survival in a preclinical model of spontaneous pancreatic cancer with induction gemcitabine/nab-paclitaxel.
Authors
Cullen M. Taniguchi
University of Texas MD Anderson Cancer Center, Houston, TX
Cullen M. Taniguchi , Jessica Molkentine , Tara N Fujimoto , Lauren Elizabeth Colbert , Amit Deorukhkar , Joseph M. Herman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 273)
DOI
10.1200/JCO.2018.36.4_suppl.273
Abstract #
273
Poster Bd #
D6
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Australasian Gastro-Intestinal Trials Group (AGITG) MASTERPLAN: Randomized phase II study of modified neoadjuvant FOLFIRINOX alone or in combination with stereotactic radiotherapy (SBRT) for patients with high-risk and locally advanced pancreatic cancer.
First Author: Andrew Oar
Poster
2019 Gastrointestinal Cancers Symposium
Dose intensity of nab-paclitaxel and gemcitabine chemotherapy in metastatic pancreatic cancer.
First Author: Alexander Lim
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Stereotactic body radiotherapy compared to conventionally fractionated radiotherapy for locally advanced or oligometastatic pancreatic cancer.
First Author: Ofri Mizrahi
Poster
2023 ASCO Annual Meeting
Clinical genomic implications of transcriptional subtypes in pancreatic cancer.
First Author: Harshabad Singh